The human metapneumovirus diagnostics market is set to continue its upward trajectory in the upcoming years, projected to reach $0.79 billion by 2029, reflecting a CAGR of 10.1%.

The latest outbreak in human metapneumovirus (HMPV), which was first detected in 2001 by Dutch scholars, is causing concern across the world as infection rates in China increase.

Hospital readmission risk in pediatric patients was higher in those who were first admitted for RSV than in those who were first admitted for influenza or hMPV.

The Classification of Human Metapneumovirus Human metapneumovirus (HMPV) has been visualized by electron microscopy, revealing a pleiomorphic morphology that is similar in appearance to that ...

The rapid identification of respiratory virus outbreaks is needed to enable rational and effective public health interventions. We developed new quantitative approaches for simultaneous ...

Vermont has the second lowest state fatality rate in the US (148.2 per 100K; Hawaii 113.6/100K). Mississippi (465.8/100K) and ...

Leading oncology centers in the United States engaged to conduct the Phase 2 Antiviral Trial and further advance the development of PUL-042 HOUSTON, TX, UNITED STATES, July 8, 2025 /EINPresswire.com/ ...

Icosavax’s pipeline of respiratory disease vaccines is headed by IVX-A12, a virus-like particle (VLP) shot that targets both RSV and human metapneumovirus (hMPV), two major causes of serious ...

Sanofi is trailing behind GSK and Pfizer when it comes to vaccines for respiratory syncytial virus (RSV), but it still thinks it can be the top player in the market with a combination of its ...

Kolkata: While Covid is on the verge of making a complete exit, other season-change viruses have started filling the void.

Season-change Viruses: As Covid cases decrease, experts are observing a resurgence of seasonal viruses including influenza and rhinovirus. This article explores the implications and warnings from ...